IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

DSM Invests in Probiotics Start Up

9:43 AM MST | November 5, 2007 | Alex Scott

DSM says its subsidiary DSM Ventures and private equity firm Capital Resource Partners (Boston, MA) have each invested in Ganeden Biotech (Mayfield Heights, OH), a manufacturer of dietary supplements for digestive health. DSM and CSP have invested a combined total of $12 million. Further details about DSM’s share of the investment were not disclosed. Ganeden’s products are based on the use of a spore-forming and lactic-acid-producing bacterium, Bacillus coagulans. DSM says the investment will contribute to the company’s innovation ambitions in...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa